Product
Botulinum Toxin
5 clinical trials
11 indications
Indication
Glabellar Frown LinesIndication
ScarIndication
Hypertrophic ScarIndication
Compartment SyndromeIndication
EpicondylitisIndication
Cold HypersensitivityIndication
Vascular System InjuriesIndication
Vibration DisorderIndication
Sensory DisordersIndication
PainIndication
NerveClinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar LinesStatus: Completed, Estimated PCD: 2020-08-07
Clinical trial
Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar MinimizationStatus: Active (not recruiting), Estimated PCD: 2024-12-30
Clinical trial
Comparison of Non-Surgical Treatment Options for Chronic Exertional Compartment Syndrome (CECS)Status: Active (not recruiting), Estimated PCD: 2024-10-01
Clinical trial
A Phase III Randomized Double-blind Study to Evaluate Efficacy of Botulinum Toxin for Treating EpicondylitisStatus: Completed, Estimated PCD: 2021-07-07
Clinical trial
Botulinum Toxin A in the Treatment of Frostbite Sequelae - a Randomized, Double Blind, Placebo-controlled StudyStatus: Withdrawn, Estimated PCD: 2023-07-01